Jubilant Pharmova Limited (NSE:JUBLPHARMA) — Stock Price

Rs962.70 INR
▲ 3.29% today

Jubilant Pharmova Limited (NSE:JUBLPHARMA) is currently trading at Rs962.70 INR, up 3.29% today. Over the past 52 weeks, shares have ranged between Rs807.65 and Rs1181.20. This page tracks Jubilant Pharmova Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Jubilant Pharmova Limited.

Jubilant Pharmova Limited (JUBLPHARMA) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Jubilant Pharmova Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Jubilant Pharmova Limited Income Statement — Revenue, Profit & Earnings by Year

Jubilant Pharmova Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Rs72.34 Billion Rs67.03 Billion Rs62.82 Billion Rs61.30 Billion Rs60.99 Billion
Cost of Revenue Rs25.36 Billion Rs23.51 Billion Rs20.82 Billion Rs14.88 Billion Rs15.36 Billion
Gross Profit Rs46.99 Billion Rs43.52 Billion Rs42.00 Billion Rs46.42 Billion Rs45.63 Billion
Research & Development — Rs148.00 Million — — —
SG&A Rs22.74 Billion Rs22.21 Billion Rs21.74 Billion Rs20.48 Billion Rs19.28 Billion
Total Operating Expenses Rs23.43 Billion Rs22.87 Billion Rs22.15 Billion Rs20.74 Billion Rs19.44 Billion
Operating Income Rs23.56 Billion Rs20.64 Billion Rs19.85 Billion Rs25.68 Billion Rs26.19 Billion
EBITDA Rs10.48 Billion Rs7.93 Billion Rs6.46 Billion Rs10.66 Billion Rs14.68 Billion
EBIT Rs8.03 Billion Rs5.23 Billion Rs3.75 Billion Rs8.40 Billion Rs11.44 Billion
Interest Expense Rs2.40 Billion Rs2.72 Billion Rs1.88 Billion Rs1.45 Billion Rs1.84 Billion
Income Before Tax Rs9.81 Billion Rs1.71 Billion Rs278.00 Million Rs6.30 Billion Rs8.71 Billion
Income Tax Expense Rs1.44 Billion Rs978.00 Million Rs927.00 Million Rs2.17 Billion Rs2.97 Billion
Net Income Rs8.39 Billion Rs771.00 Million Rs-610.00 Million Rs4.14 Billion Rs8.36 Billion

Jubilant Pharmova Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Jubilant Pharmova Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Rs127.56 Billion Rs115.48 Billion Rs111.57 Billion Rs99.91 Billion Rs89.18 Billion
Total Current Assets Rs35.77 Billion Rs38.76 Billion Rs37.62 Billion Rs35.09 Billion Rs29.53 Billion
Cash & Equivalents — — — — —
Short-term Investments Rs5.00 Million Rs4.00 Million Rs3.84 Million Rs53.53 Million Rs1.87 Billion
Net Receivables Rs8.93 Billion Rs12.51 Billion Rs10.51 Billion Rs11.42 Billion Rs8.69 Billion
Inventory Rs11.29 Billion Rs13.04 Billion Rs14.21 Billion Rs12.86 Billion Rs11.43 Billion
Property, Plant & Equipment — — Rs33.65 Billion Rs27.91 Billion Rs25.75 Billion
Goodwill Rs25.41 Billion Rs24.64 Billion Rs24.29 Billion Rs22.43 Billion Rs21.30 Billion
Total Liabilities Rs65.18 Billion Rs61.27 Billion Rs57.65 Billion Rs46.74 Billion Rs41.77 Billion
Total Current Liabilities Rs21.65 Billion Rs18.89 Billion Rs17.72 Billion Rs15.92 Billion Rs10.49 Billion
Long-term Debt Rs21.50 Billion Rs31.67 Billion Rs31.10 Billion Rs24.64 Billion Rs25.64 Billion
Net Debt Rs16.42 Billion Rs27.10 Billion Rs26.63 Billion Rs22.12 Billion Rs23.32 Billion
Total Stockholder Equity Rs62.55 Billion Rs54.34 Billion Rs53.99 Billion Rs53.19 Billion Rs47.41 Billion
Retained Earnings Rs53.02 Billion Rs45.35 Billion Rs45.37 Billion Rs46.85 Billion Rs43.18 Billion

Jubilant Pharmova Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Jubilant Pharmova Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Rs10.72 Billion Rs9.71 Billion Rs6.61 Billion Rs8.38 Billion Rs17.84 Billion
Capital Expenditures Rs11.16 Billion Rs8.98 Billion Rs8.14 Billion Rs6.00 Billion Rs5.27 Billion
Free Cash Flow Rs-435.00 Million Rs736.00 Million Rs-1.54 Billion Rs2.38 Billion Rs12.57 Billion
Investing Cash Flow Rs4.88 Billion Rs-6.08 Billion Rs-5.44 Billion Rs-3.80 Billion Rs-7.39 Billion
Financing Cash Flow Rs-14.53 Billion Rs-4.33 Billion Rs-1.57 Billion Rs-325.99 Million Rs-17.09 Billion
Dividends Paid Rs796.00 Million Rs798.00 Million Rs800.60 Million Rs800.53 Million Rs14.75 Million
Stock-Based Compensation Rs43.00 Million Rs85.00 Million Rs36.50 Million Rs11.24 Million Rs2.46 Million
Depreciation Rs3.69 Billion Rs3.82 Billion Rs5.54 Billion Rs3.82 Billion Rs4.52 Billion
Change in Cash Rs1.32 Billion Rs-575.00 Million Rs301.00 Million Rs4.82 Billion Rs-7.29 Billion

Jubilant Pharmova Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Jubilant Pharmova Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 22, 2026 — 8.00 —
Feb 06, 2026 5.01 6.90 -27.39%
Oct 31, 2025 7.85 7.10 +10.56%
Jul 17, 2025 — — —
May 16, 2025 9.83 8.50 +15.65%
Jan 31, 2025 6.36 6.10 +4.26%
Oct 25, 2024 7.14 4.90 +45.71%
Jul 19, 2024 6.32 44.20 -85.70%